Argyle Capital Management Inc. Merck & Co., Inc. Transaction History
Argyle Capital Management Inc.
- $240 Million
- Q2 2024
A detailed history of Argyle Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Argyle Capital Management Inc. holds 56,723 shares of MRK stock, worth $6.68 Million. This represents 2.92% of its overall portfolio holdings.
Number of Shares
56,723
Previous 60,408
6.1%
Holding current value
$6.68 Million
Previous $7.97 Million
11.89%
% of portfolio
2.92%
Previous 3.13%
Shares
26 transactions
Others Institutions Holding MRK
# of Institutions
3,825Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$28.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$24.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.54 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.72 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $299B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...